PK of Efavirenz & Lopinavir Nano-formulations in Healthy Volunteers
Status:
Suspended
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is an open-label, prospective pharmacokinetic study investigating two
antiretroviral agents in parallel and employing an adaptive design with two stages, whereby
the results obtained in the primary stage inform the doses selected for investigation in the
secondary stage